The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia
Status:
Completed
Trial end date:
2020-01-02
Target enrollment:
Participant gender:
Summary
This randomized, double-blinded, placebo-controlled, crossover clinical trial aims to
investigate the effect of VGH-BPH1, a scientific Chinese medicine powder prescription, on
patients with benign prostatic hyperplasia.